Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. [electronic resource]
Producer: 19981026Description: 657-60 p. digitalISSN:- 0742-3071
- 1-Deoxynojirimycin -- analogs & derivatives
- Adult
- Aged
- Blood Glucose -- metabolism
- C-Peptide -- blood
- Diabetes Mellitus, Type 2 -- drug therapy
- Double-Blind Method
- Enzyme Inhibitors -- adverse effects
- Fasting
- Female
- Follow-Up Studies
- Glucosamine -- adverse effects
- Glycated Hemoglobin -- analysis
- Glycoside Hydrolase Inhibitors
- Humans
- Hypoglycemic Agents -- adverse effects
- Imino Pyranoses
- Insulin -- therapeutic use
- Male
- Middle Aged
- Postprandial Period
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.